Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02409732 · ClinicalTrials.gov registry record · Phase 4
Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis
A Phase 4 study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT02409732 is a Phase 4 study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT02409732, a Phase 4 study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
To evaluate the safety and efficacy of PDT with blue light and topical Levulan in the treatment of actinic cheilitis.
Interventions
- DRUG aminolevulinic acid hydrochloride
- PROCEDURE Photodynamic therapy with blue light
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-04 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02409732
The ClinicalTrials.gov registry entry for NCT02409732 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which aminolevulinic acid hydrochloride is the first listed.
NCT02409732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02409732 about?
NCT02409732 is a clinical study titled "Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis". To evaluate the safety and efficacy of PDT with blue light and topical Levulan in the treatment of actinic cheilitis.
What is the current status of trial NCT02409732?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2015-04. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02409732?
The interventions under investigation include: aminolevulinic acid hydrochloride (DRUG), Photodynamic therapy with blue light (PROCEDURE).
Who is sponsoring clinical trial NCT02409732?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.